Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-10

Clinical Trial Update: PGE2/IL-22 Pathway in Various Forms of Eczema

View source ↗

Summary

NHS Lothian reports the completion of a clinical trial investigating the PGE2/IL-22 pathway in eczema. The study pertains to atopic dermatitis and has reached c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NHS Lothian | Conditions: Eczema | Status: COMPLETED